Muscle Pharm Corp MSLP
We take great care to ensure that the data presented and summarized in this overview for MusclePharm Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MSLP
Top Purchases
Top Sells
About MSLP
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Insider Transactions at MSLP
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 29
2022
|
White Winston Select Asset Fund Series Fund Mp 18, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
626,826
-17.18%
|
-
|
Sep 27
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,556
+0.21%
|
$0
$0.53 P/Share
|
Sep 27
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,444
+0.33%
|
$0
$0.53 P/Share
|
Aug 20
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,100
+0.84%
|
$0
$0.4 P/Share
|
Aug 19
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,900
+0.41%
|
$0
$0.4 P/Share
|
Aug 15
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,600
+0.39%
|
$0
$0.4 P/Share
|
Aug 14
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,400
+0.46%
|
$0
$0.41 P/Share
|
Aug 05
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,560
+0.22%
|
$0
$0.5 P/Share
|
Aug 05
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,440
+0.33%
|
$0
$0.5 P/Share
|
Apr 08
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,530
+0.56%
|
$0
$0.6 P/Share
|
Apr 08
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,176
+0.84%
|
$0
$0.6 P/Share
|
Mar 19
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,617
+0.22%
|
$0
$0.63 P/Share
|
Mar 19
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,469
+0.34%
|
$0
$0.63 P/Share
|
Mar 06
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,112
+0.52%
|
$0
$0.63 P/Share
|
Mar 06
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,096
+0.83%
|
$0
$0.63 P/Share
|
Feb 07
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,740
+2.18%
|
$0
$0.4 P/Share
|
Feb 07
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
13,860
+1.89%
|
$0
$0.4 P/Share
|
Feb 06
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,260
+3.36%
|
$0
$0.4 P/Share
|
Feb 06
2019
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,140
+2.91%
|
$0
$0.4 P/Share
|
Dec 31
2018
|
Wynnefield Partners Small Cap Value LP I > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
27,925
+2.5%
|
$0
$0.57 P/Share
|